The defective glycosylation of α-dystroglycan is associated with a group of muscular dystrophies that are collectively referred to as the secondary dystroglycanopathies. The gene discussed is DAG1; the disease is qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan.